Kano Task Force: 890 Pregabalin Drug Convictions Amidst Abuse Surge

• The Kano State Multi-Agency Task Force has arrested 1,760 drug suspects and secured 890 convictions.
• Authorities seized 3.18 million pregabalin capsules, identifying it as the most abused substance in Kano.
• Eight out of ten suspected drug users arrested were linked to pregabalin.
• Task force chairman Muhuyi Rimingado expressed concern over pregabalin's continued availability despite regulations.
• Rimingado called for stronger inter-agency collaboration and drastic action against accomplices in public office.

The fight against drug abuse in Kano State has reached a pivotal juncture, demanding decisive action against individuals who may be complicit in the illicit drug trade.

The Kano State Multi-Agency Task Force on Drug Abuse and Illicit Trafficking has voiced significant alarm regarding the escalating misuse and widespread distribution of pregabalin within the region. In response to this growing challenge, the task force has undertaken extensive operations targeting drug-related offenses, leading to a substantial number of arrests and convictions. These efforts underscore a concerted push to curb the illicit drug trade and its impact on public health and safety.

During recent operations, the task force successfully apprehended 1,760 individuals suspected of drug-related activities. Concurrently, these enforcement actions have resulted in 890 convictions, demonstrating a notable success rate in prosecuting offenders. A key focus of these interventions has been pregabalin, with authorities seizing an impressive 3.18 million capsules of the substance, highlighting the scale of its illicit circulation in Kano.

Muhuyi Rimingado, the chairman of the task force, revealed these figures during a press briefing on Saturday, November 15, 2026, emphasizing the critical role pregabalin plays in the local drug abuse landscape. According to Rimingado, pregabalin stands out as the most commonly abused substance across Kano. This assertion is supported by arrest data, which indicates that a significant majority—eight out of every ten suspected drug users detained by the task force—were either found in possession of the drug or confessed to its use.

Further details on the outcomes for the 1,760 arrested suspects illustrate the various paths taken through the justice system. While 890 individuals have been convicted, 63 are currently awaiting trial. Approximately 690 of those arrested have been placed in correctional facilities, reflecting the severity of their offenses. The remaining individuals have been directed towards rehabilitation programs, subjected to fines, or assigned community service, indicating a multi-faceted approach to addressing drug-related infractions beyond incarceration.

Despite the task force's vigorous enforcement activities, Chairman Rimingado expressed deep concern over the continued widespread availability of pregabalin on the streets, even in the face of existing regulatory measures designed to control its distribution. He articulated a frustration with the current situation, stating that it is difficult to justify pursuing drug users—whom he views as victims—when those responsible for trafficking the drugs appear to be protected by entities that are statutorily obligated to prevent such access. This highlights a perceived disconnect between enforcement efforts and the broader regulatory environment.

Rimingado underscored the necessity for enhanced cooperation among various regulatory agencies. He issued a stark warning that the overall fight against drug abuse would inevitably be undermined if the institutions tasked with overseeing access to restricted medicines fail to adequately perform their duties. This call for improved inter-agency collaboration points to a recognition that effective drug control requires a unified and robust front from all relevant government bodies.

The chairman further stressed that the campaign against drug abuse in Kano State has reached a pivotal juncture, demanding decisive action against individuals who may be complicit in the illicit drug trade. He specifically targeted those who might be exploiting their positions of public office, effectively transforming a privilege into an environment conducive to illegal drug trafficking. This strong statement signals a readiness to pursue accountability at all levels, including within governmental structures, to dismantle the networks facilitating drug abuse.

This intensified focus on Kano pregabalin drug convictions and the broader Kano drug law enforcement efforts reflects a critical moment for the region. The task force's operations, including significant Nigeria drug trafficking arrests, are clearly aimed at disrupting supply chains and holding both users and, more critically, distributors and their enablers responsible. The statements from Muhuyi Rimingado indicate a determination to address not just the symptoms but also the systemic issues contributing to the pregabalin abuse Kano is experiencing.

Lawyers advising pharmaceutical companies, distributors, or healthcare providers in Kano, Nigeria, should note the intensified enforcement against pregabalin abuse and trafficking. This signals increased regulatory scrutiny and potential for more aggressive investigations or prosecutions related to controlled substance supply chains, necessitating a review of compliance protocols and risk exposure.

Source: Original reporting via Healthwise